fashion -WSS

fashion

author：hotspot 2025-10-01 00:48:17 - browse：4753

Yiwei Shi holds her son Leo -- health coverage from STAT — Yiwei Shi with her son Leo Courtesy Yiwei Shi

Two years ago, Yiwei Shi was searching desperately for someone to build a drug for her newborn son, Leo. Leo was born with a very small head, a symptom of many severe diseases. After a seizure at two months, doctors sequenced his genome and found a single misspelling in a gene called TNPO2.

Little was known about the gene, except that it was involved in neurodevelopment. The most recent paper the family found was in fruit flies. Only one other boy in the world had been identified with Leo’s mutation. Shi contacted the family.

“And we found out from the family that at about age 3, the other boy stopped kind of making progress developmentally,” Shi said. “We were like, time is of the essence.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： STAT Virtual Event: The State of Biosimilars: What to Watch

WSS

FDA's Pazdur wants cancer trials to range beyond China alone

Medicare to cover more brain scans for Alzheimer’s patients

Listen: Wegovy in the brain & pivotal Alzheimer's data

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

FDA approves RSV monoclonal antibody for infants, toddlers

focus

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

After affirmative action ruling, medical educators look to 'holistic review'

ASCO: Palliative care found as helpful given virtually as in person

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

BMI, flaws aside, is found to be useful estimate of body fat in youth

Moonlake's readout produced a cash windfall. Risks remain

Cord blood banking comes at a high cost to babies

23andMe had bad news about my health. I wish a person had delivered it

Ultragenyx gene therapy for rare liver ailment succeeds in late

Virginia high school admissions case could be legal follow

WHO calls for emergency meeting on new China virus, as cases spread

hotspot

Shifting the focus from loneliness to social health

Change Healthcare can notify patients about the breach, HHS says

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

ASCO: AstraZeneca says CAR

With trial win, GSK could get blood cancer drug back on market

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

leisure time

hotspot

hotspot

leisure time